Babu Yarlagadda S - Insider Stock Trading - OpenInsider

CIK: 1452635 - Address: 4505 Emperor Blvd., Suite 200, Durham, NC 27703

14 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	11	-1	-2	3	-6	1	-57	-10
S	%wins				64	73	36	64	55	100	65

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/16/22 16:19	11/14/22	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	Chief Di	S.d	-437	13.88	0	-32	-10	299	D
3/9/22 16:24	3/7/22	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	Chief Di	S	-343	17.16	0	-20	-8	230	D
12/9/21 16:38	12/7/21	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	Chief Di	S.d	-367	12.20	0	-30	-12	215	D
8/29/16 10:46	8/25/16	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	SVP - Dr	S	-122	4.06	7	-30	-21	111	D	-69	-63	110	24	38	0	-3	-10	-1	0	14	42	49
3/20/15 16:30	3/19/15	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	SVP - Dr	S	-123	10.16	8	-12	-8	149	D	693	-10	-9	0	-4	0	7	2	-5	-14	8	49	42	-67
3/6/15 14:14	3/5/15	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	SVP - Dr	S	-396	10.59	8	-37	-19	161	D	739	-20	-21	-3	-4	1	-1	0	-2	-6	-5	21	12	-75
3/5/15 14:58	3/4/15	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	SVP - Dr	S	-110	10.50	8	-10	-5	198	D	767	-18	-18	2	-2	5	0	3	-2	-8	-7	17	7	-75
3/7/14 16:14	3/4/14	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	SVP - Dr	S.d	-511	12.57	14	-41	-16	208	D	162	901	85	102	1	23	-4	-1	0	-4	-19	-7	11	-11
3/5/12 14:30	3/2/12	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	VP Drug	S.d	-4	4.78	2	-1	-1	126	D	-30	12	42	63	65	22	12	4	19	19	6	-38	-9	-74
2/23/12 16:40	2/22/12	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	NC	O	VP Drug	S.d	-130	4.22	2	-31	-37	53	D	-36	4	66	49	67	18	9	5	2	11	26	-22	-5	-72
10/28/09 10:14	10/26/09	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	AL	O	VP Drug	S	-69	10.85	22	-6	-14	39	D	32	539	181	3	-3	28	12	7	-13	-12	-18	-39	-21	-53
10/22/09 13:29	10/21/09	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	AL	O	VP Drug	S	-2	10.00	16	0	0	46	D	21	392	446	11	-12	24	15	1	3	-4	9	-29	-23	-46
10/21/09 16:40	10/20/09	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	AL	O	VP Drug	S	-34	10.00	16	-3	-7	46	D	18	365	411	17	-15	12	5	-3	3	11	14	-27	-25	-49
9/24/09 15:23	9/23/09	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Babu Yarlagadda S	AL	O	VP Drug	S	-183	9.14	33	-20	-29	49										-10	-10	8	-34	-27	-47

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact